# Esperion Therapeutics Inc. (ESPR) — Operating Income

## Annual Operating Income (USD)

| Year | Operating Income |
| --- | --- |
| 2025 | $60M |
| 2024 | $54M |
| 2023 | -$156M |
| 2022 | -$180M |
| 2021 | -$227M |
| 2020 | -$121M |
| 2019 | -$93M |
| 2018 | -$205M |

## Quarterly Operating Income (USD)

| Quarter | Operating Income |
| --- | --- |
| 2026-03-31 | -$7M |
| 2025-09-30 | -$10M |
| 2025-06-30 | $7M |
| 2025-03-31 | -$22M |
| 2024-09-30 | -$16M |
| 2024-06-30 | $3M |
| 2024-03-31 | $72M |
| 2023-09-30 | -$28M |
| 2023-06-30 | -$37M |
| 2023-03-31 | -$49M |
| 2022-09-30 | -$42M |
| 2022-06-30 | -$52M |
| 2022-03-31 | -$43M |
| 2021-09-30 | -$56M |
| 2021-06-30 | -$33M |
| 2021-03-31 | -$83M |
| 2020-09-30 | -$81M |
| 2020-06-30 | $129M |
| 2020-03-31 | -$74M |
| 2019-09-30 | -$66M |
| 2019-06-30 | -$55M |
| 2019-03-31 | $87M |

Source: [CompaniesByCap](https://companiesbycap.com/company/ESPR/operating-income)